Mark whether the assessment finding represents a therapeutic result of the Bisacodyl administered, a non therapeutic side-effect, or an unrelated finding.

Choice A rationale
The patient is receiving a nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) for HIV
treatment and reports experiencing malaise, fatigue, and anorexia. These symptoms, along
with the observed increased respiratory rate, could be indicative of liver toxicity, a known
potential side effect of NRTIs. Therefore, reviewing liver function tests would be most
important in this case.
Choice B rationale
While arterial blood gases can provide valuable information about a patient’s respiratory
status, they may not be the most relevant in this context. The patient’s symptoms and the side
effect profile of NRTIs suggest that liver function may be a more pressing concern.

Choice C rationale
A complete blood count (CBC) can provide a broad overview of a patient’s general health, but it
may not provide the specific information needed to assess the patient’s current symptoms and
potential medication side effects.
Choice D rationale
A basic metabolic panel can provide information about a patient’s kidney function, electrolyte
levels, and blood sugar levels, among other things. However, given the patient’s symptoms and
medication regimen, liver function tests may be more relevant.

Choice A rationale

A pain rating of 2/10 is not directly related to the therapeutic effect of Bisacodyl. Bisacodyl is a stimulant laxative used to treat constipation, and its effectiveness would not typically be measured by pain ratings20.

Choice B rationale

A non-blanchable red area could be a sign of a pressure ulcer or other skin condition. It is not a therapeutic result of Bisacodyl administration20.

Choice C rationale

Blood pressure of 135/81 mmHg is a normal reading and is not directly related to the therapeutic effect of Bisacodyl20.

Choice D rationale

Sinus tachycardia, or a faster-than-normal heart rate, is not a therapeutic result of Bisacodyl administration. If a patient experiences sinus tachycardia while taking Bisacodyl, they should seek medical attention20.

Choice E rationale

Itching in legs is not a therapeutic result of Bisacodyl administration. It could be a sign of an allergic reaction or other medical condition20.

Choice F rationale

Semifluid stool is the correct answer. Bisacodyl is a stimulant laxative that works by increasing activity in the intestines to cause a bowel movement. Therefore, the production of semifluid stool can be considered a therapeutic result of Bisacodyl administration20.

Choice G rationale

A burning sensation is not a therapeutic result of Bisacodyl administration. If a patient experiences a burning sensation while taking Bisacodyl, they should seek medical attention20.